NEW YORK (GenomeWeb News) – A review panel at the California Institute of Regenerative Medicine (CIRM) this week will decide whether to approve $40 million to fund several proposals to launch new research centers that would use genomics to pursue human biology, disease, and therapeutics studies.

CIRM's board will decide in a public meeting on Jan. 29 which applications, if any, will receive the funds, which the board set aside for two years specifically for stem cell genomics initiatives.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.